Armenien - engelska - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

gedeon richter plc - haloperidol - solution for i/m injection - 5mg/ml

Israel - engelska - Ministry of Health

j-c health care ltd - haloperidol as decanoate - solution for injection - haloperidol as decanoate 100 mg/ml - haloperidol - maintainance therapy of chronic schizophrenic patients.

Irland - engelska - HPRA (Health Products Regulatory Authority)

janssen-cilag ltd - haloperidol decanoate - solution for injection - 50 milligram(s)/millilitre - butyrophenone derivatives; haloperidol

Irland - engelska - HPRA (Health Products Regulatory Authority)

janssen sciences ireland uc - haloperidol - solution for injection - 100 milligram(s)/millilitre - butyrophenone derivatives; haloperidol

Irland - engelska - HPRA (Health Products Regulatory Authority)

janssen sciences ireland uc - haloperidol - solution for injection - 50 milligram(s)/millilitre - butyrophenone derivatives; haloperidol

Israel - engelska - Ministry of Health

j-c health care ltd - haloperidol - tablets - haloperidol 5 mg - haloperidol - haloperidol - haldol is indicatedin adult patients aged 18 years and above for:• treatment of schizophrenia and schizoaffective disorder.• acute treatment of delirium when non-pharmacological treatments have failed.• treatment of moderate to severe manic episodes associated with bipolar i disorder when other treatments cannot be used.• treatment of acute psychomotor agitation associated with psychotic disorder or manic episodes of bipolar i disorder.• treatment of persistent aggression and psychotic symptoms in patients with moderate to severe alzheimer’s dementia and vascular dementia when non-pharmacological treatments have failed and when there is a risk of harm to self or others.• treatment of tic disorders, including tourette’s syndrome, in patients with severe impairment after educational, psychological and other pharmacological treatments have failed.• treatment of mild to moderate chorea in huntington’s disease, when other medicinal products are ineffective or not tolerated.in paediatric patients for:• schizophrenia in adolescents aged 13 to 17 years when other pharmacological treatments have failed or are not tolerated.• persistent, severe aggression in children and adolescents aged 6 to 17 years with autism or pervasive developmental disorders, when other treatments have failed or are not tolerated. • tic disorders, including tourette’s syndrome, in children and adolescents aged 10 to 17 years with severe impairment after educational, psychological and other pharmacological treatments have failed.

Israel - engelska - Ministry of Health

j-c health care ltd - haloperidol - solution (oral) - haloperidol 2 mg/ml - haloperidol - haloperidol - haldol is indicatedin adult patients aged 18 years and above for:• treatment of schizophrenia and schizoaffective disorder.• acute treatment of delirium when non-pharmacological treatments have failed.• treatment of moderate to severe manic episodes associated with bipolar i disorder when other treatments cannot be used.• treatment of acute psychomotor agitation associated with psychotic disorder or manic episodes of bipolar i disorder.• treatment of persistent aggression and psychotic symptoms in patients with moderate to severe alzheimer’s dementia and vascular dementia when non-pharmacological treatments have failed and when there is a risk of harm to self or others.• treatment of tic disorders, including tourette’s syndrome, in patients with severe impairment after educational, psychological and other pharmacological treatments have failed.• treatment of mild to moderate chorea in huntington’s disease, when other medicinal products are ineffective or not tolerated.in paediatric patients for:• schizophrenia in adolescents aged 13 to 17 years when other pharmacological treatments have failed or are not tolerated.• persistent, severe aggression in children and adolescents aged 6 to 17 years with autism or pervasive developmental disorders, when other treatments have failed or are not tolerated. • tic disorders, including tourette’s syndrome, in children and adolescents aged 10 to 17 years with severe impairment after educational, psychological and other pharmacological treatments have failed.

Israel - engelska - Ministry of Health

cts chemical industries ltd, israel - haloperidol - tablets - haloperidol 10 mg - haloperidol - haloperidol - management of psychotic disorders . control of tics and vocal utterances of tourette's disorder in children and adults.

Israel - engelska - Ministry of Health

cts chemical industries ltd, israel - haloperidol - tablets - haloperidol 0.5 mg - haloperidol - haloperidol - management of psychotic disorders. control of tics and vocal utterances of tourette's disorder in children.

Israel - engelska - Ministry of Health

cts chemical industries ltd, israel - haloperidol - tablets - haloperidol 5.00 mg - haloperidol - haloperidol - management of psychotic disorders. control of tics and vocal utterances of touratte's disorder in children and adults.